P1696: ECONOMIC BURDEN IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) FOR PATIENTS WITH ≥2 PRIOR LINES OF THERAPY INCLUDING A BRUTON TYROSINE KINASE INHIBITOR (BTKI) AND/OR B-CELL LYMPHOMA...

por Priyadarshini, Masoom, Deshpande, Gaurav, Tiwana, Simran K, Le, T. Kim, Garrison, Sean, Awan, Farrukh
Publicado 2023

6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death

por Bernstein, Alison I, Garrison, Sean P, Zambetti, Gerard P, O'Malley, Karen L
Publicado 2011

PB2696: QUALITATIVE INTERVIEWS TO DESCRIBE BURDEN IN PATIENTS (PT) WITH THIRD-LINE OR LATER CLL/SLL WITH PRIOR EXPOSURE TO BRUTON TYROSINE KINASE INHIBITOR (BTKI) AND/OR B-CELL LYM...

por Priyadarshini, Masoom, Balantac, Zaneta, Tiwana, Simran K, Bapat, Shweta S, Garrison, Sean, Martin, Mona L
Publicado 2023

The p53-Target Gene Puma Drives Neutrophil-Mediated Protection against Lethal Bacterial Sepsis

por Garrison, Sean P., Thornton, Justin A., Häcker, Hans, Webby, Richard, Rehg, Jerold E., Parganas, Evan, Zambetti, Gerard P., Tuomanen, Elaine I.
Publicado 2010